Patents by Inventor Maxime Gualtieri

Maxime Gualtieri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10626144
    Abstract: The invention provides for novel peptide derivatives and compositions comprising the same. The invention further provides methods of treatment comprising administering novel peptide derivatives and/or compositions comprising the same.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: April 21, 2020
    Assignee: Nosopharm
    Inventors: Philippe Villain-Guillot, Maxime Gualtieri, Emilie Racine
  • Publication number: 20170298097
    Abstract: The invention provides for novel peptide derivatives and compositions comprising the same. The invention further provides methods of treatment comprising administering novel peptide derivatives and/or compositions comprising the same.
    Type: Application
    Filed: September 25, 2015
    Publication date: October 19, 2017
    Inventors: Philippe Villain-Guillot, Maxime Gualtieri, Emilie Racine
  • Patent number: 9260481
    Abstract: The present invention relates to antibiotic compounds, methods for producing said compounds, pharmaceutical compositions comprising said compounds, and methods of treatment comprising administering said compounds and/or compositions comprising said compounds.
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: February 16, 2016
    Assignees: Nosopharm, Institut National de la Recherche Agronomique
    Inventors: Maxime Gualtieri, Philippe Villain-Guillot, Alain Givaudan, Sylvie Pages
  • Publication number: 20150175659
    Abstract: The present invention relates to antibiotic compounds, methods for producing said compounds, pharmaceutical compositions comprising said compounds, and methods of treatment comprising administering said compounds and/or compositions comprising said compounds.
    Type: Application
    Filed: September 28, 2012
    Publication date: June 25, 2015
    Applicants: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE, NOSOPHARM
    Inventors: Maxime Gualtieri, Philippe Villain-Guillot, Alain Givaudan, Sylvie Pages
  • Publication number: 20100227935
    Abstract: The present invention relates to a new class of terpene-derived compounds having an antibiotic activity and of the formulae (I) or (II) in which A is selected from NR1, O, S, CR2R3 or R—(CH2)n—R?, wherein R and R? represent independently NH, O, S or CH2, and in which R1, R2 et R3 are substituents and n is higher than or equal to 1, in particular equal to 2. The invention relates to the compound according to both the formula (I) or the formula (II) taken individually, to mixtures of the two compounds, and to compositions, mainly therapeutic ones, comprising at least one of the compounds or said mixture. According to a particular embodiment, the compound ((I) or (II) taken individually, the mixtures of both compounds and the compositions of the invention are used in the treatment of difficult C-related digestive infections. In one particular embodiment, the compound of the formula (I) is margaucine, a compound produced by a bacterial stem.
    Type: Application
    Filed: September 21, 2007
    Publication date: September 9, 2010
    Applicants: Centre National De La Recherche Scientifique, Universite De Provence-Aix-Marseille 1, Universite Paul Cezanne-Aix-Marseille 3
    Inventors: Jean-Paul Leonetti, Maxime Gualtieri, Laurence Coulibeuf, Gaëtan Herbette